Morgan Stanley Keeps Their Sell Rating on Avanos Medical (AVNS) - The Globe and Mail

Retrieved on: 2024-06-28 18:26:24

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley Keeps Their Sell Rating on Avanos Medical (AVNS) - The Globe and Mail. View article details on hiswai:

Excerpt

Morgan Stanley analyst Drew Ranieri maintained a Sell rating on Avanos Medical (AVNS – Research Report) today and set a price target of $28.00.

Article found on: www.theglobeandmail.com